Alcoholism Clinical and Experimental Research · 2005 · 14 citations · 9 references
NursingPharmacologyAlcohol ToxicologyClinical PharmacologySubstance Use DisordersAddiction AssessmentAlcohol Use DisorderAlcohol Metabolite BiomarkersAlcohol ScreeningAlcohol Use Disorder ScreeningCapillary ElectrophoresisCapillary Zone ElectrophoresisControl Group DesignMatched Control GroupZone Electrophoresis
BACKGROUND: The spectrum of alcohol use disorders covers hazardous use, alcohol abuse, and alcohol dependence. The present study evaluated the performance of asialotransferrin, a newly proposed biomarker for alcohol use disorders, in detecting alcohol abuse and alcohol dependence. METHOD: A 4-month trial was conducted in three groups of participants: alcohol abusers and alcohol-dependent patients, as defined in DSM-IV, and a control group. Asialotransferrin was assayed by capillary zone electrophoresis. RESULTS: Asialotransferrin demonstrated a sensitivity of 0.34 and a specificity of 1.00 for alcohol abuse. The sensitivity of asialotransferrin increased to 0.57 in alcohol-dependent patients. CONCLUSION: Despite the high specificity of asialotransferrin in alcohol use disorders, its sensitivity is too low to make it a useful marker of alcohol abuse.
9
Michel Reynaud, François Schellenberg, Marie‐Nadia Loisequx‐Meunier et al. · Alcoholism Clinical and Experimental Research · 2000 · 72 citations
High ethanol intake and malnutrition in alcoholic cerebellar shrinkage
José M. Nicolás · QJM · 2000 · 62 citations · Full text
Pharmacy, Neurology, Neuroscience +16